RFD2-MI designs sequence-specific cysteine proteases
RFD2-MI designs cysteine-nucleophile proteases that cleave peptide backbones in a sequence-dependent manner. The preprint abstract reports rate enhancements up to 3 × 10^7 and crystal structures close to design models. The journal version reports additional experiments; this draft is bounded to the preprint abstract result and does not transfer later results across versions.
Technology: RFD2-MI; ProteinMPNN; AlphaFold 3
Family ProteinMPNN: profile · models page
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: The source reports the study-specific result summarized here.
- Still unknown: Independent replication and broader deployment or clinical benefit are not established by this source review.
- AI role: RFD2-MI generates catalytic protein structures; sequence design and structure prediction support experimental selection.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12668006/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 16 Nov 2026. Review scope: Primary-source abstract and publication metadata reviewed; full text scope is specified in source_checks..
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.